Skip to main content
. Author manuscript; available in PMC: 2019 Dec 31.
Published in final edited form as: Am J Gastroenterol. 2010 Feb 9;105(5):1133–1139. doi: 10.1038/ajg.2010.9

Table 4.

Testing results stratified by indication

HACAs Therapeutic IFX Non-therapeutic IFX Non-interpretable
Loss of response/partial response (n=110) 19 (17) 36 (33) 50 (45) 5 (5)
Autoimmune/delayed hypersensitivity reactions (n=16) 6 (38) 5 (31) 4 (25) 1 (6)
Acute infusion reaction (n=5) 1 (20) 3 (60) 1 (20)
Reintroduction after drug holiday (n=7) 6 (86) 1 (14)

HACAs, human anti-chimeric antibodies; IFX, infliximab.